Morgan Stanley »

Global X Fds genomic biotech shares owned by Morgan Stanley

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $154k 14k 11.38
2023-09-30 $128k 13k 10.17
2023-06-30 $156k 13k 12.12
2022-12-31 $49k 3.8k 12.65
2022-06-30 $139k 11k 12.13
2022-03-31 $173k 11k 15.08
2021-06-30 $295k 12k 24.79
2020-12-31 $95k 4.0k 23.51
2020-09-30 $6.0k 325 18.46